 |
March 1, 2010
Vol. XXVII, No. 9
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
Tailored Statin Interventions Help Prevent CAD Events |
|
A tailored treatment strategy appears to help prevent more coronary artery disease (CAD) events while treating fewer people with high-dose statins than LDL cholesterol-based target approaches, according to a national study. Researchers compared tailored treatments based on a person’s 5-year CAD risk with treat-to-target approaches that escalate statin doses per National Cholesterol Education Program (NCEP) III guidelines. When compared with a standard NCEP III approach, an intensive NCEP III approach treated 15 million more people and saved 570,000 more quality-adjusted life-years (QALYs) over 5 years. The tailored strategy treated a similar number of persons, but saved 500,000 more QALYs and treated fewer people with high-dose statins.
Source: Annals of Internal Medicine, January 19, 2010.
|
|
REFERENCE LINKS:
|
|
An abstract of the study is available at www.annals.org.
|
|
|
| |
|
|
|
|
|
| To get Physician's Weekly posted in your hospital, click HERE |
|
|
